Browse News
Filter News
Found 512,834 articles
-
The industry group PhRMA released its 2018 PhRMA member annual survey along with the 2018 Biopharmaceutical Research Industry Profile. Among the findings was that overall research-and-development spending was at an all-time high in 2017, hitting $71.4 billion, up from $65.5 billion in 2016 and fr...
-
Janssen Pharmaceutical Companies from Johnson & Johnson, confirmed topline data from its Phase III Antiretroviral Therapy as Long-Acting Suppression (ATLAS) trial of its two-drug combination for HIV.
-
Generally speaking, the larger the animal, the more cells they have, the more likely they are to get cancer. The longer an animal lives, even if that animal is a human being, the higher the likelihood of cancer. Except elephants. Elephants rarely get cancer.
-
Foster City, Calif.-based Gilead Sciences reorganized some of its executive leadership team after it was announced that Chief Medical Officer Andrew Cheng is leaving the company to pursue other opportunities.
-
RXi Pharmaceuticals, headquartered in Marlborough, Mass., signed a research collaboration deal with Sweden’s Karolinska Institute. They will work to develop cancer therapies using RXi’s sd-rxRNA compounds against targets involved in T-cell and NK cell differentiation.
-
It’s not easy to predict trends in drugs, especially with breakthroughs in immunology and genetic engineering often causing dramatic changes in how biopharma companies approach new drugs.
-
Express Scripts is already known for its role of bringing prescriptions to the doors of consumers. Now the company is moving into a new area of providing medicines—expensive gene therapies.
-
Days after it closed on a $42 million Series A funding round, Karuna Pharmaceuticals has named a new chief executive officer. The company appointed industry veteran and founder of Sage Therapeutics Steven Paul as its new top officer.
-
Here's Five Vaccines to Keep Your Eye on
8/15/2018
On a dollar-for-dollar basis, vaccines have probably had a greater positive effect on global health than any other medical advancement, except possibly antibiotics. Yet as a whole, it’s an area that pharma companies tend to not spend a lot of resources on. But there are still many companies that ... -
You’ve done the research, had a great idea, and worked hard to make it a success. However, when the time comes to address the achievement with others in the organization, your boss takes the credit!
-
CytoDyn Announces Strong Preclinical Results Using PRO 140 in Human Colon Carcinoma
8/15/2018
CytoDyn will file an IND, along with a proof-of-concept protocol for colon cancer
-
Brain Imaging Study Demonstrates Digital Psychiatric Therapy “Re-Wires” the Brain, Resulting in Improved Attention in Children with ADHD
8/15/2018
Study in Translational Psychiatry suggests promise of durable non-pharmacologic treatment
-
Oragenics, Inc. Resumes Phase 2 Clinical Trial of AG013 in Oral Mucositis Following Positive Routine Safety Review
8/15/2018
AG013 is a live biotherapeutic product for the potential treatment of OM following a positive review by an independent Data Safety Monitoring Board (DSMB).
-
Merck Foundation Supports New Programs to Improve Care for Alzheimer's Patients And Caregivers in the United States
8/15/2018
These programs are part of the Foundation's $5 million effort to reduce disparities in health care for underserved communities affected by Alzheimer's
-
Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer
8/15/2018
US Oncology Research will open 10 clinical trial sites, enrolling patients in Novocure’s PANOVA-3 trial to test the efficacy of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine in patients with unresectable locally advanced pancreatic cancer
-
Nation's Largest Suicide Prevention Organization Thanks President Donald J. Trump for Signing the National Suicide Hotline Improvement Act of 2018 (H.R. 2345)
8/15/2018
On Tuesday, August 14, President Donald Trump signed the National Suicide Hotline Improvement Act. John Madigan, senior vice president of public policy for the American Foundation for Suicide Prevention (AFSP), the nation's largest suicide prevention organization, released this statement thanking the President:
-
ProQR to Present Interim Phase 1/2 Results for QR-110 in Leber’s Congenital Amaurosis 10 at the Symposium for Retinal Degeneration on Sept. 5th
8/15/2018
Presentation at the 18th International Symposium on Retinal Degeneration (RD2018) at 8:30 am GMT on Sept. 5th
-
Arjo unveils IndiGo -- breakthrough technology for medical bed transport
8/15/2018
First-of-its-kind, customer-focused solution delivers intuitive user experience
-
PASCO Introduces Complete STEM Bridge-Building Kit to Help Students Learn and Apply Engineering Concepts
8/15/2018
The Building Better Bridges Kit allows students to build, test, and redesign their structures quickly and efficiently to support the engineering process
-
FDA Approves KALYDECO® (ivacaftor) as First and Only Medicine to Treat the Underlying Cause of CF in Children Ages 12 to 24 Months with Certain Mutations in the CFTR Gene
8/15/2018
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved KALYDECO® (ivacaftor) to include use in children with cystic fibrosis (CF) ages 12 to <24 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to KALYDECO based on clinical and/or in vitro assay data.